keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CMV pp65(13-27) is a bioactive peptide derived from the 65k lower matrix phosphoprotein of the human cytomegalovirus, specifically comprising amino acid residues 13 to 27. It includes a nine-amino-acid sequence (LGPISGHVL) that corresponds to the consensus binding motif for the major histocompatibility complex H2-Dd T-cell epitope.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | CMV pp65(13-27) is a bioactive peptide derived from the 65k lower matrix phosphoprotein of the human cytomegalovirus, specifically comprising amino acid residues 13 to 27. It includes a nine-amino-acid sequence (LGPISGHVL) that corresponds to the consensus binding motif for the major histocompatibility complex H2-Dd T-cell epitope. |
Molecular Weight | 1523.82 |
Formula | C72H118N18O18 |
CAS No. | 357643-84-6 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CMV pp65(13-27) 357643-84-6 inhibitor inhibit